IQVIA Holdings Inc
IQVIA Holdings Inc. provides clinical research services, commercial insights, and healthcare intelligence to the life sciences and healthcare industries in the Americas, Europe, Africa, and the Asia-Pacific. It operates through three segments: Technology & Analytics Solutions, Research & Development Solutions, and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment of… Read more
IQVIA Holdings Inc - Asset Resilience Ratio
IQVIA Holdings Inc (IQV) has an Asset Resilience Ratio of 7.15% as of December 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2011–2025)
This chart shows how IQVIA Holdings Inc's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down IQVIA Holdings Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $1.98 Billion | 6.61% |
| Short-term Investments | $161.00 Million | 0.54% |
| Total Liquid Assets | $2.14 Billion | 7.15% |
Asset Resilience Insights
- Limited Liquidity: IQVIA Holdings Inc maintains only 7.15% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
IQVIA Holdings Inc Industry Peers by Asset Resilience Ratio
Compare IQVIA Holdings Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF |
Diagnostics & Research | 1.12% |
|
Berry Genomics Co Ltd
SHE:000710 |
Diagnostics & Research | 0.45% |
|
NSN Co. Ltd
KQ:031860 |
Diagnostics & Research | 1.72% |
|
JOONGANG DNM Co.Ltd
KQ:051980 |
Diagnostics & Research | 27.26% |
|
GeneMatrix Inc
KQ:109820 |
Diagnostics & Research | 41.52% |
|
Genoray Co. Ltd
KQ:122310 |
Diagnostics & Research | 0.03% |
|
Green Cross Lab Cell Corporation
KQ:144510 |
Diagnostics & Research | 0.18% |
|
Optipharm.CO.LTD
KQ:153710 |
Diagnostics & Research | 20.73% |
Annual Asset Resilience Ratio for IQVIA Holdings Inc (2011–2025)
The table below shows the annual Asset Resilience Ratio data for IQVIA Holdings Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 7.15% | $2.14 Billion | $29.94 Billion | +0.30pp |
| 2024-12-31 | 6.85% | $1.84 Billion | $26.90 Billion | +1.24pp |
| 2023-12-31 | 5.61% | $1.50 Billion | $26.68 Billion | +0.44pp |
| 2022-12-31 | 5.17% | $1.31 Billion | $25.34 Billion | -0.82pp |
| 2021-12-31 | 5.98% | $1.48 Billion | $24.69 Billion | -1.76pp |
| 2020-12-31 | 7.74% | $1.90 Billion | $24.56 Billion | +3.88pp |
| 2019-12-31 | 3.87% | $899.00 Million | $23.25 Billion | -0.29pp |
| 2018-12-31 | 4.16% | $938.00 Million | $22.55 Billion | -0.26pp |
| 2017-12-31 | 4.42% | $1.00 Billion | $22.74 Billion | -1.42pp |
| 2016-12-31 | 5.84% | $1.24 Billion | $21.21 Billion | +6.68pp |
| 2015-12-31 | -0.84% | $-32.91 Million | $3.93 Billion | +0.21pp |
| 2014-12-31 | -1.04% | $-34.50 Million | $3.31 Billion | +0.27pp |
| 2013-12-31 | -1.32% | $-40.35 Million | $3.07 Billion | +0.12pp |
| 2012-12-31 | -1.44% | $-35.95 Million | $2.50 Billion | -0.49pp |
| 2011-12-31 | -0.95% | $-22.11 Million | $2.32 Billion | -- |